Insight https://www.bioworld.com/rss en-us Money raised by biotech: 2019 vs. 2018 http://www.bioworld.com/articles/429226 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429226-money-raised-by-biotech-2019-vs-2018 Phase III clinical trials: September 2019 http://www.bioworld.com/articles/429222 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429222-phase-iii-clinical-trials-september-2019 Week in Washington http://www.bioworld.com/articles/429223 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429223-week-in-washington Phase II clinical trials: September 2019 http://www.bioworld.com/articles/429224 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429224-phase-ii-clinical-trials-september-2019 Phase I clinical trials: September 2019 http://www.bioworld.com/articles/429225 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429225-phase-i-clinical-trials-september-2019 BioWorld stock report for public biotechnology companies http://www.bioworld.com/articles/429216 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429216-bioworld-stock-report-for-public-biotechnology-companies The week's biggest gainers and losers http://www.bioworld.com/articles/429217 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429217-the-week-s-biggest-gainers-and-losers Gene therapy offers potential but poses logistical challenges http://www.bioworld.com/articles/429218 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429218-gene-therapy-offers-potential-but-poses-logistical-challenges 3Q deals and M&A: volumes down, values up; 2019 already topping last two years http://www.bioworld.com/articles/429219 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429219-q-deals-and-ma-volumes-down-values-up-2019-already-topping-last-two-years Word on the street http://www.bioworld.com/articles/429220 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429220-word-on-the-street Week in review http://www.bioworld.com/articles/429221 Mon, 14 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429221-week-in-review Biotech money raised by month in 2019 (US$M) http://www.bioworld.com/articles/429250 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429250-biotech-money-raised-by-month-in-2019-us-m Public financing of biotechnology companies: Commenced trading in September 2019 http://www.bioworld.com/articles/429251 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429251-public-financing-of-biotechnology-companies-commenced-trading-in-september-2019 Public financing of biotechnology companies: Filed and pending IPOs in September 2019 http://www.bioworld.com/articles/429252 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429252-public-financing-of-biotechnology-companies-filed-and-pending-ipos-in-september-2019 Other financings of public biotechnology companies in September 2019 http://www.bioworld.com/articles/429253 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429253-other-financings-of-public-biotechnology-companies-in-september-2019 Milestone payments from corporate partners in September 2019 http://www.bioworld.com/articles/429254 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429254-milestone-payments-from-corporate-partners-in-september-2019 Investors give biopharma companies cold shoulder in September http://www.bioworld.com/articles/429243 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429243-investors-give-biopharma-companies-cold-shoulder-in-september Solid quarter for sector's global public and private financings http://www.bioworld.com/articles/429244 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429244-solid-quarter-for-sectors-global-public-and-private-financings Nasdaq Stock Index 2019 http://www.bioworld.com/articles/429245 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429245-nasdaq-stock-index-2019 BioWorld Stock Index 2019 http://www.bioworld.com/articles/429246 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429246-bioworld-stock-index-2019 Venture capital and other investments in private biotech companies in September 2019 http://www.bioworld.com/articles/429247 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429247-venture-capital-and-other-investments-in-private-biotech-companies-in-september-2019 Money raised by biotech: 2019 vs. 2018 http://www.bioworld.com/articles/429248 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429248-money-raised-by-biotech-2019-vs-2018 Biopharma money raised: Jan. 1 - Sept. 30, 2019 http://www.bioworld.com/articles/429249 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429249-biopharma-money-raised-jan-1-sept-30-2019 BioWorld stock report for public biotechnology companies http://www.bioworld.com/articles/429239 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429239-bioworld-stock-report-for-public-biotechnology-companies The week's biggest gainers and losers http://www.bioworld.com/articles/429240 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429240-the-week-s-biggest-gainers-and-losers Week in Washington http://www.bioworld.com/articles/429241 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429241-week-in-washington Week in review http://www.bioworld.com/articles/429242 Mon, 07 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429242-week-in-review Three late-stage drugs look to battle in Cushing's syndrome market http://www.bioworld.com/articles/429176 Mon, 30 Sep 2019 00:00:00 -0400 https://www.bioworld.com/articles/429176-three-late-stage-drugs-look-to-battle-in-cushings-syndrome-market Money raised by biotech: 2019 vs. 2018 http://www.bioworld.com/articles/429177 Mon, 30 Sep 2019 00:00:00 -0400 https://www.bioworld.com/articles/429177-money-raised-by-biotech-2019-vs-2018 The week's biggest gainers and losers http://www.bioworld.com/articles/429178 Mon, 30 Sep 2019 00:00:00 -0400 https://www.bioworld.com/articles/429178-the-week-s-biggest-gainers-and-losers